Right now, in Canada, there's a battle going on for its citizens' genes, as health insurance companies are using genome sequencing to assess risk (read: increase rates) for patients who are predisposed to certain diseases.
The country's privacy commissioner issued a policy statement last week saying that the government would really appreciate if health insurance companies left genetic testing out of whatever actuarial algorithms they're using, but hasn't banned the practice outright.
While Canada has universal health care that's highly
subsidized by (and often free for consumers), there are still plenty of
private insurers. And, right now, the country's health insurance
industry has instituted a voluntary moratorium on asking people to
specifically undergo genetic testing when they apply for coverage. But
that doesn't mean it never happens—it just happens in a different way.
If a person has already undergone genetic testing in the past, insurance
companies will regularly request that data from a prospective client's
doctors.
"If genetic testing has been done
and the information is available to the applicant for insurance and/or
the applicant’s physician, the insurer would request access to that
information just as it would for other aspects of the applicant’s health
history," the Canadian Life and Health Insurance Association stated as its official policy on the issue.
The practice sets a pretty scary precedent that some have worried about for years—what
happens when and if a baby is genetically tested at birth and is
determined to be a risky investment for an insurance company? Some
countries, including the United States have (sort of) already banned the
practice, but there's still no law against it in Canada.
“Some of these tests—as time goes on, and now—are
important indicators with respect to risk,” Frank Zinatelli, a lawyer
with the CLHIA, told Canada's Globe and Mail. “So yes, we feel it’s important to be able to have access to those types of information.”
An insurance company flak would say that. There's
no denying that knowing whether someone is predisposed to having
Alzheimer's or Parkinson's or certain types of cancer is valuable
information for an insurance company. It's, perhaps, the most important
thing an insurance company can learn about a person, from a business
standpoint.
It's also why the United States, a country that seemingly
protects its citizens' privacy much less than Canada does passed a ban
on genetic discrimination back in 2008. There are loopholes in that law,
sure (it only covers health insurance and employment, not life
insurance), but it's better than any sort of "voluntary moratorium,"
especially when the industry is champing at the bit to expand the
practice. Meanwhile, a bill that would actually ban genetic
discrimination has been sitting in Canadian parliament since October, with little indication that it's going to move forward.
Source: www.parl.gc.ca/LEGISInfo/BillDetails.aspx?Language=E&Mode=1&billId=6257110
No comments:
Post a Comment
Thank you for your comments.
Canadian Insurance News does not endorse any of the views posted. By submitting your comments, you acknowledge that we have the right to reproduce, broadcast and publicize those comments or any part thereof in any manner whatsoever.